These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15565127)

  • 1. Replacement therapy, not recreational tonic.
    Jones RD; Jones TH; Channer KS
    Nature; 2004 Nov; 432(7016):439. PubMed ID: 15565127
    [No Abstract]   [Full Text] [Related]  

  • 2. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone replacement therapy for older men.
    Wald M; Meacham RB; Ross LS; Niederberger CS
    J Androl; 2006; 27(2):126-32. PubMed ID: 16474018
    [No Abstract]   [Full Text] [Related]  

  • 4. Xyosted--a testosterone auto-injector for hypogonadism.
    Med Lett Drugs Ther; 2019 Mar; 61(1567):37-38. PubMed ID: 30845097
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 6. Counterpoint: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
    Casey RW
    Can J Urol; 2002 Dec; 9(6):1681-3. PubMed ID: 12517309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement therapy.
    Jones TH
    Br J Hosp Med (Lond); 2007 Oct; 68(10):547-53. PubMed ID: 17974303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
    Maganty A; Osterberg EC; Ramasamy R
    Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uses and misuses of testosterone therapy.
    Johns Hopkins Med Lett Health After 50; 2006 Aug; 18(6):3, 7. PubMed ID: 16921650
    [No Abstract]   [Full Text] [Related]  

  • 14. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
    Seftel A
    Int J Impot Res; 2007; 19(1):2-24. PubMed ID: 16193074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone and the primary care physician.
    Tomlinson JM
    Int J Clin Pract; 2007 Apr; 61(4):538-9. PubMed ID: 17394425
    [No Abstract]   [Full Text] [Related]  

  • 16. Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    Pharm Res; 2006 Jun; 23(6):1117-32. PubMed ID: 16755346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heart risk due to testosterone?].
    Grätzel P
    MMW Fortschr Med; 2015 Apr; 157(6):27. PubMed ID: 26015192
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone therapy: many players and much controversy.
    Sigman M
    Fertil Steril; 2015 May; 103(5):1144-5. PubMed ID: 25934600
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormone replacement therapy in men: practical aspects].
    Gamidov SI; Shcherbakov DV; Tazhetdinov OKh; Pavlovichev AA; Iremashvili VV
    Urologiia; 2011; (4):68, 70-3. PubMed ID: 22066247
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism.
    Kaminetsky JC; Moclair B; Hemani M; Sand M
    J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.